Ambry Genetics
在场
Ambry Genetics 的所有者是 Konica Minolta.
是其中之一......
Konica Minolta 是一家在股票代码 4902 (JP) 下上市的公司。
Konica Minolta 在 12 个国家有直接业务。Konica Minolta 拥有 16家子公司，其中包括 Ambry Genetics、Invicro 和 Konica Minolta Australia。
他们在：
高管
查看带有其 10 名主要高管的组织结构图
Ambry Genetics 搜索最多的简介
- Tom Schoenherr, Chief Executive Officer
- Brigette Davis, Chief Operating Officer and Chief Scientific Offic...
- Elizabeth Chao, Chief Medical Officer
高管在Konica Minolta变化
- Yusuke Yoshimura 曾任 Corporate Senior Vice President, General Manager, FORXAI Business Operations, 将于 20244月1 现任 Senior Vice President and Executive Officer, Imaging Solution Business (新闻发布的2024三月5号).
- Hiroyuki Uemura 曾任 Deputy General Manager, Quality Management Headquarters, 将于 20244月1 现任 Senior Vice President and Executive Officer, Corporate Quality Management (新闻发布的2024三月5号).
- Ken Osuga 曾任 Corporate Senior Vice President, Strategic Project, 将于 20244月1 现任 Senior Vice President and Executive Officer, Business Development, Business Technologies (新闻发布的2024三月5号).
创建提醒
跟踪 Ambry Genetics 的高管变动
生物技术
Konica Minolta 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
- Metsera 刚刚宣布为 500 筹款数百万美元。 (公布2024十一月20号).
- TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).
生物技术 行业的其他推荐联系人
消息
Ambry Genetics 的最新新闻稿
- Letter from Tom Schoenherr, CEO: Definitive Agreement for Acquisition of Ambry Genetics by Tempus AI
- Ambry Genetics Announces New Hereditary Cancer Test Menu at NSGC Annual Conference
- Ambry Genetics Announces New Multiomic Exome Test for Improved Rare Disease Detection
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
- Ambry Genetics Announces a Collaboration with Tempus to Advance Paired Germline and Somatic Testing Services for Medical Oncologists
- Ambry Genetics Unveils at ASHG New Insights on the Use of Multiomic Testing in 43,000 Patient Study
- LifeStrands Genomics and Ambry Genetics to Provide Laboratory Testing for Clinical Implementation Pilots in Phase II of Singapore’s National Precision Medicine Programme
- Unilabs and Ambry Sign Agreement to Enhance Genetic Testing Services for Biopharma Companies in Europe, Latin America and the Middle East
- Ambry’s New Reproductive Health Program Uses Digital Platform to Make It Easier for Patients to Access Genetic Screening Before and During Pregnancy
- Ambry Genetics Publishes 43,000 Patient Study Showing Combined RNA and DNA Analysis Identifies Patients Who Are High-Risk for Cancer but Would Have Been Missed by DNA Testing Alone
- View more press releases Close
通过电子邮件
